We are live on ! Find out more
ZCM

Zebra Capital Management Portfolio holdings

AUM $20M
1-Year Est. Return 2.24%
This Fund
S&P 500
This Quarter Est. Return
+8.5%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$113M
AUM Growth
+$21.1M
Cap. Flow
+$13.9M
Cap. Flow %
12.36%
Top 10 Hldgs %
10.55%
Holding
348
New
118
Increased
122
Reduced
52
Closed
56

Sector Composition

Rank Sector Weight
1 Financials 17.64%
2 Industrials 16.64%
3 Consumer Discretionary 15.21%
4 Healthcare 13.18%
5 Technology 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEE icon
276
Lee Enterprises
LEE
$175M
$64K 0.06%
4,519
-5,222
-54% -$93.1K
SRGA
277
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$61K 0.05%
737
-535
-42% -$37.5K
ARAY icon
278
Accuray
ARAY
$27.5M
$58K 0.05%
20,662
+9,118
+79% +$25.3K
PFSW
279
DELISTED
PFSweb, Inc.
PFSW
$57K 0.05%
+14,920
New +$50.6K
LITS
280
Lite Strategy Inc
LITS
$32.4M
$56K 0.05%
1,135
+501
+79% +$18.6K
HPR
281
DELISTED
HighPoint Resources Corporation
HPR
$52K 0.05%
611
+348
+132% +$22.7K
ABEO icon
282
Abeona Therapeutics
ABEO
$355M
$50K 0.04%
+607
New +$42.8K
ELVT
283
DELISTED
Elevate Credit, Inc.
ELVT
$48K 0.04%
10,832
-5,867
-35% -$24.5K
HBIO icon
284
Harvard Bioscience
HBIO
$27.6M
$45K 0.04%
+1,460
New +$42K
EVC icon
285
Entravision Communication
EVC
$1.02B
$43K 0.04%
+16,288
New +$44.5K
CSLT
286
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$43K 0.04%
32,538
+14,359
+79% +$20K
PVLA
287
Palvella Therapeutics
PVLA
$2.05B
$36K 0.03%
+125
New +$34.7K
ENZ
288
DELISTED
Enzo Biochem, Inc.
ENZ
$26K 0.02%
+10,056
New +$30K
ZVO
289
DELISTED
Zovio Inc. Common Stock
ZVO
$24K 0.02%
+11,541
New +$23.1K
FTSI
290
DELISTED
FTS International, Inc. Common Stock
FTSI
$20K 0.02%
955
+32
+3% +$861
ARC
291
DELISTED
ARC Document Solutions, Inc.
ARC
$18K 0.02%
+12,756
New +$16.6K
TTSH
292
DELISTED
Tile Shop Holdings
TTSH
$17K 0.02%
+10,079
New +$23.9K
ADUS icon
293
Addus HomeCare
ADUS
$2.22B
-2,989
Closed -$237K
AMED
294
DELISTED
Amedisys
AMED
-5,522
Closed -$724K
AMKR icon
295
Amkor Technology
AMKR
$10.6B
-69,467
Closed -$632K
AVD icon
296
American Vanguard Corp
AVD
$68.7M
-15,179
Closed -$238K
BLBD icon
297
Blue Bird Corp
BLBD
$2.29B
-11,803
Closed -$225K
BOOM icon
298
DMC Global
BOOM
$111M
-5,834
Closed -$257K
CENTA icon
299
Central Garden & Pet Co Class A
CENTA
$2.43B
-33,039
Closed -$733K
EPM icon
300
Evolution Petroleum
EPM
$133M
-11,064
Closed -$65K

Similar funds

Zebra Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Zebra Capital Management held 348 positions worth $113M, up 23% from $91.5M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Zebra Capital Management deployed $13.9M of net new capital in Q4 2019, opening 118 new positions and adding to 122 existing holdings. Its largest new stake was Denny's: 55,989 shares worth $1.11M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Builders FirstSource, an estimated $981K trimmed.

  • Zebra Capital Management's largest Q4 2019 buy was Denny's: 55,989 shares worth $1.11M.
  • Zebra Capital Management added most to Meridian Bioscience Inc in Q4 2019, an estimated $630K increase.
  • Zebra Capital Management's biggest Q4 2019 reduction was Builders FirstSource, cutting an estimated $981K.
  • Zebra Capital Management fully exited AVX Corporation in Q4 2019, selling an estimated $1.52M.
  • Zebra Capital Management's ten largest holdings make up 11% of its $113M portfolio in Q4 2019.
  • Zebra Capital Management opened 118 new positions and closed 56 in Q4 2019.
  • Zebra Capital Management's portfolio value rose 23% quarter-over-quarter to $113M.

Based on Zebra Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.